May 22, 2025
Vaxart Announces Adjournment of Annual Meeting of Stockholders
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted…
Pharmaceuticals, Biotechnology and Life Sciences
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted…
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…
PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) — Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”),…
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage…
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient…
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company…
– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES,…
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (“MediPharm” or the “Company”), a pharmaceutical company specialized…
Annual General Meeting of Ipsen S.A. held on 21 May 2025 All the resolutions submitted to the shareholders’…
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies OSE Immunotherapeutics to lead French consortium with Inside Therapeutics and…